Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPOX | P50336 | 2/20 | 0.41 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.40 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MYC | P01106 | 1/20 | 0.38 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.37 |
| ▸ | FYN | P06241 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24939826 | 0.86 | PPOX (0.51) | PPOXGRM7GRM4 | |
| SCHEMBL24939836 | 0.84 | MYC (0.44) | USP2POLBL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL24939825 | 0.80 | ALDH1A1 (0.59) | USP2POLBL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL24939838 | 0.77 | MYC (0.41) | PPOXUSP2POLBL3MBTL1KDM4E | |
| SCHEMBL24939829 | 0.76 | ALDH1A1 (0.47) | KDM4EALDH1A1HPGD | |
| SCHEMBL11014765 | 0.75 | PPOX (0.44) | PPOXKDM4EALDH1A1HPGD | |
| SCHEMBL10717840 | 0.75 | PPOX (0.65) | PPOXALDH1A1 | |
| SCHEMBL24939680 | 0.74 | CA12 (0.50) | POLBALDH1A1MRGPRX4 | |
| SCHEMBL10765350 | 0.72 | GRM7 (0.39) | GRM7GRM4 | |
| SCHEMBL3387534 | 0.72 | ALDH1A1 (0.56) | KDM4EALDH1A1HPGDMRGPRX4LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | GFER, LBR, PCNA | PPOX 2277/4885GRM7 1547/4885GRM4 503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.